Sabra Healthcare REIT Inc (SBRA)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NASDAQ
Market Cap: $5.35B
Last updated: Nov 17, 2026 at 11:06 AM ET
Sabra Healthcare REIT Inc (SBRA) Stock Forecast
Sabra Healthcare REIT (SBRA) has an FFO per share estimate of $1.67 for 2026. Analysts expect EPS of $0.33 for the fiscal year ending Dec 31, 2026, on revenue of $865.40M. Of 16 analysts, 6 rate the stock Buy or Strong Buy, 10 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 4 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 16 ratings average 2.56, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 38% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 6.3% |
| Buy | 5 | 31.3% |
| Hold | 10 | 62.5% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 16
Price Target
Analyst price targets are part of paid GNG plans. See plans
FFO Estimates
FFO per share is expected at $1.67 for 2026, up 8.4% from $1.54 in 2025, and at $1.71 for 2027, up 2.4%.
- FFO per share, 2026
- $1.67
- Estimate
- FFO per share, 2027
- $1.71
- Estimate
- Fiscal year ending Dec 31, 2026
- $0.33
- EPS consensus, revenue $865.40M
- Next report
- Feb 10, 2027
- Estimated
| Fiscal year | Basis | FFO per share | Change |
|---|---|---|---|
| 2025 | Actual | $1.54 | N/A |
| 2026 | Estimate | $1.67 | +8.4% |
| 2027 | Estimate | $1.71 | +2.4% |
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 121.2% and revenue estimates rise 15.3%.
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.33 | $0.31 to $0.35 | 4 | $865.40M | $575.13M to $957.05M | 5 |
| Dec 31, 2027 | $0.73 | $0.68 to $0.77 | 2 | $997.90M | $630.13M to $1.14B | 8 |
Quarterly Estimates
The EPS consensus falls from $0.18 for the quarter ending Dec 31, 2026 to $0.16 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.18 | $0.16 to $0.22 | 10 | $248.53M | $214.23M to $273.60M | 12 |
| Mar 31, 2027 | $0.16 | $0.16 to $0.16 | 1 | $254.33M | $241.13M to $272.94M | 6 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 3 upward and 4 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 4 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
| Quarter ending Mar 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 49.2% from $0.65.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.33 | $0.40 | $0.45 | $0.48 | $0.65 | -49.8% |
| Fiscal year ending Dec 31, 2027 | $0.73 | $0.81 | $0.81 | $0.81 | $0.78 | -6.7% |
| Quarter ending Mar 31, 2027 | $0.16 | $0.20 | $0.20 | $0.20 | $0.18 | -11.1% |
Frequently Asked Questions About SBRA
What is the SBRA stock forecast?
Sabra Healthcare REIT's FFO per share estimate for 2026 is $1.67. Consensus analyst estimates put Sabra Healthcare REIT's EPS at $0.33 for the fiscal year ending Dec 31, 2026, on revenue of $865.40M. The consensus rating from 16 analysts is Hold.
How do analysts rate SBRA stock?
Of 16 analysts covering Sabra Healthcare REIT, 1 rates it Strong Buy, 5 Buy, 10 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from SBRA next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.33, with estimates from $0.31 to $0.35 from 4 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.73, with estimates from $0.68 to $0.77 from 2 analysts.
What revenue do analysts expect from Sabra Healthcare REIT next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $865.40M, with estimates from $575.13M to $957.05M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $997.90M, with estimates from $630.13M to $1.14B.
How many analysts cover SBRA?
16 analysts rate Sabra Healthcare REIT stock, and 4 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
SBRA pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors